Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

Clinical trial NCT06294600 · RECRUITING

Trial details

NCT number: NCT06294600
Sponsor: Hellenic Institute for the Study of Sepsis
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Community-acquired Pneumonia

Start date: 2024-02-12
Primary completion: 2026-04-05
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.